General Pain

Latest

Better Benefit-to-Risk Ratio for Anti-CGRP mAbs Than Current Migraine Preventive Medication

By

Rose Reeb

The researchers compared anti-CGRP mAbs with other drugs for the prevention of episodic and chronic migraine using a likelihood to help versus harm analysis.

Lucira Check It Test Kit Available OTC for At-Home COVID-19 Testing

By

Brian Park, PharmD

The Lucira Check It COVID-19 test kit utilizes a molecular amplification technology to detect SARS-CoV-2 RNA.

Antibody Response to COVID-19 Vaccine Lower in Hemodialysis Population

By

Natasha Persaud

Age was an important factor in the humoral response, regardless of chronic medical conditions.

Considerable Neurologic, Psychiatric Morbidity Reported After COVID-19

In the six months after COVID-19 infection, there is considerable neurologic and psychiatric morbidity.

First Living Donor Transplant of Lung Tissue to COVID-19 Patient Announced

The world’s first transplant of lung tissue from living donors to a COVID-19 patient with severe lung damage was announced by doctors in Japan.

Risk for COVID-19 Infection From Surfaces Is Low

The risk for catching the new coronavirus from surfaces is low, according to the US Centers for Disease Control and Prevention.

Neuropathic Pain Etiology Leads to Variable Health-Related Quality of Life Measures

By

Lauren Biscaldi

One aim of this study was to compare breast cancer survivors and HIV patients, both with neuropathic pain, with regard to psychological factors and health-related quality of life.

Case Report: Pain Med Dose Linked to Patient’s Sleepwalking

By

Cassandra Pardini, PharmD

The patient, who had suffered a traumatic brain injury approximately 8 months prior, presented to the emergency department complaining of increasing dizziness as well as sleepwalking frequency.

Oral COVID-19 Vaccine Being Tested

California researchers are testing whether an oral vaccine offers similar or better protection than current COVID-19 shots.

NIH Starts Trial Looking at Rare Allergic Reactions to COVID-19 Vaccines

A new clinical trial will investigate sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines.